Publication:
Neopterin and soluble CD14 (sCD14) levels as immunoactivation markers in aHBc-only cases

No Thumbnail Available

Date

2017-08-01

Authors

Dinc, Harika Oyku
SOHRABİ, Pari
Habip, Zafer
Saribas, Suat
Vatan, Asli
Altun, Yagiz M.
ZİVER, Tevhide
Caliskan, Reyhan
Demirci, Mehmet
Uysal, Omer

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Metrics

Search on Google Scholar

Abstract

Aim: Isolated hepatitis B core antibodies (aHBc)-only pattern complicates the diagnosis of HBV infections. We evaluated neopterin and sCD14 levels in HBV infections. Methods: aHBc-only (n: 102), healthy control (healthy control group [HCG], n: 100), and chronic hepatitis (CHB) groups (n: 70) were investigated. Competitive and sandwich ELISA were used. Results: The mean neopterin levels were significantly lower in the aHBc-only group than those in the CHB group (p = 0.0001). No significant difference was found between the aHBc-only group and the HCG (p = 0.854). The mean sCD14 levels were lower in the aHBc-only group than those in the CHB group (p = 0.0001), but no significant difference was found between the aHBc-only group and HCG (p = 0.402). No significant difference was detected between aHBc-only and HCG for mean sCD14 (p = 0.402) and neopterin levels (p = 0.854). Conclusion: These two biomarkers are not useful for diagnosing the aHBc only pattern.

Description

Keywords

Citation

SOHRABİ P., Habip Z., Saribas S., Vatan A., Dinc H. O. , Altun Y. M. , ZİVER T., Caliskan R., Demirci M., Uysal O., et al., -Neopterin and soluble CD14 (sCD14) levels as immunoactivation markers in aHBc-only cases-, FUTURE VIROLOGY, cilt.12, ss.409-419, 2017
Page Views

0

File Downloads

0

Sustainable Development Goals